Ahai Luvai

Aug 1, 2024 | bjcardio.co.uk | David Austin |Paul Williams |Ahai Luvai |Pyotr Telyuk

Large-scale observational data have demonstrated a robust, independent association of elevated lipoprotein(a) (Lp[a]) levels with atherosclerotic cardiovascular disease (CVD), stroke, and peripheral artery disease. Elevated Lp(a) concentrations in patients with ischaemic heart disease have been linked to higher rates of peri-procedural myocardial infarction (MI) during percutaneous coronary intervention (PCI).